• info@esgwise.org
AECOM Launches Energy Transition Infrastructure Team

AECOM Launches Energy Transition Infrastructure Team

Dallas-based Infrastructure firm AECOM announced today the launch of a new Energy Transition team, aimed at helping clients to address the challenges and opportunities of the energy transition in Europe. According to the company, the new team is being established in response to needs expressed by European clients and partners, including industrial hubs and port authorities, to prepare for transition…

GRI Appoints Robin Hodess as New CEO

GRI Appoints Robin Hodess as New CEO

The Global Reporting Initiative (GRI) announced today the appointment of Robin Hodess as the organization’s new CEO, beginning in February 2025. Hodess has held a variety of international leadership roles spanning strategy, governance, advocacy, policy and research, and she joins GRI from her current position as Chief of Strategy and Impact for The B Team, a nonprofit that advocates for…

EU Fund Withdrawals Not Necessarily Cause for Alarm

Assets in Luxembourg-domiciled ESG funds continue to rise, but institutional investors are broadening their horizons as tensions build between short- and long-term priorities. The realities behind recent institutional investor withdrawals from Luxembourg-domiciled ESG funds hold greater complexity than first meets the eye, according to the lead author on new research. The latest benchmark report from PwC Luxembourg, co-published with the…

GRI appoints Hodess as CEO

GRI has appointed Robin Hodess as the firm’s new chief executive, beginning in February 2025. Hodess will join from her current position as chief of strategy and impact for The B Team, the non-profit initiative aimed to promote business practices that are more centred on humanity and the climate. Hodess joins with 18 years’ experience in senior leadership roles with…

KBI Global Investors appoints natural resources portfolio manager

KBI Global Investors has appointed Craig Bonthron (pictured) as a senior portfolio manager on the firm’s natural resources equity strategies. Bonthron brings over 20 years experience to the role, having managed positive impact funds most of his career. His most recent role came at Artemis, which followed a six year stint as an investment manager with Kames Capital – now…

Three ways to invest in the new tech-driven era of medicine 

Advances in biotechnology and artificial intelligence are enabling scientists to develop more effective treatments with fewer side effects.  As a new standard of treatment rapidly emerges, widespread adoption stands to create tremendous market growth. Our research suggests the AI-enabled drug discovery market alone will grow more than six times over in just six years, reaching a $3.9bn valuation by 2027. …